1. Home
  2. COCP vs CPIX Comparison

COCP vs CPIX Comparison

Compare COCP & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COCP
  • CPIX
  • Stock Information
  • Founded
  • COCP N/A
  • CPIX 1999
  • Country
  • COCP United States
  • CPIX United States
  • Employees
  • COCP N/A
  • CPIX N/A
  • Industry
  • COCP Biotechnology: Pharmaceutical Preparations
  • CPIX Biotechnology: Pharmaceutical Preparations
  • Sector
  • COCP Health Care
  • CPIX Health Care
  • Exchange
  • COCP Nasdaq
  • CPIX Nasdaq
  • Market Cap
  • COCP 18.3M
  • CPIX 17.2M
  • IPO Year
  • COCP N/A
  • CPIX 2009
  • Fundamental
  • Price
  • COCP $1.99
  • CPIX $2.36
  • Analyst Decision
  • COCP Strong Buy
  • CPIX
  • Analyst Count
  • COCP 1
  • CPIX 0
  • Target Price
  • COCP $7.00
  • CPIX N/A
  • AVG Volume (30 Days)
  • COCP 14.9K
  • CPIX 5.5M
  • Earning Date
  • COCP 11-13-2024
  • CPIX 11-07-2024
  • Dividend Yield
  • COCP N/A
  • CPIX N/A
  • EPS Growth
  • COCP N/A
  • CPIX N/A
  • EPS
  • COCP N/A
  • CPIX N/A
  • Revenue
  • COCP N/A
  • CPIX $36,785,442.00
  • Revenue This Year
  • COCP N/A
  • CPIX N/A
  • Revenue Next Year
  • COCP N/A
  • CPIX N/A
  • P/E Ratio
  • COCP N/A
  • CPIX N/A
  • Revenue Growth
  • COCP N/A
  • CPIX N/A
  • 52 Week Low
  • COCP $1.33
  • CPIX $1.04
  • 52 Week High
  • COCP $3.10
  • CPIX $3.05
  • Technical
  • Relative Strength Index (RSI)
  • COCP 51.27
  • CPIX 66.16
  • Support Level
  • COCP $1.83
  • CPIX $2.07
  • Resistance Level
  • COCP $2.07
  • CPIX $2.93
  • Average True Range (ATR)
  • COCP 0.11
  • CPIX 0.26
  • MACD
  • COCP -0.01
  • CPIX 0.08
  • Stochastic Oscillator
  • COCP 44.74
  • CPIX 53.06

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

Share on Social Networks: